Game over for RSV?
- PMID: 37276355
- PMCID: PMC11528347
- DOI: 10.1126/sciimmunol.adi8764
Game over for RSV?
Abstract
Passive immunization with nirsevimab protects infants from severe RSV disease without impairing the immune response to natural infection.
Comment on
-
Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants.Nat Med. 2023 May;29(5):1172-1179. doi: 10.1038/s41591-023-02316-5. Epub 2023 Apr 24. Nat Med. 2023. PMID: 37095249 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
